Showing results (31-40 of 43) with videos related to
Sort By:
Pageof 5
Ceska Gynekologie|August 19, 2016
[Vulvodynia and the possibility of its management]J Kestránek, V Matula, V Pidrman, et al.Folia Microbiologica|July 11, 2006
Primer R108 performs best in the RAPD strain typing of three Aspergillus species frequently isolated from patientsV Raclaský, J Trtková, L Rusková, et al.Epidemiologie, Mikrobiologie, Imunologie : Casopis Spolecnosti Pro Epidemiologii a Mikrobiologii Ceske Lekarske Spolecnosti J.E. Purkyne|March 6, 2008
[Multidisciplinary approach to the management of vulvovaginal discomfort]J Kestránek, V Buchta, J Spacek, et al.Ceska Gynekologie|June 7, 2017
[Contemporary technicqes in diagnostic patients with vaginal microbiota]D Leško, V Buchta, M Salavec, et al.Ceska Gynekologie|October 25, 2007
[Systemic immunity in patients with recurrent vulvovaginal candidiasis]P Jílek, J Spacek, V Buchta, et al.Ceska Gynekologie|May 28, 2005
[Chlamydia infections in urogenital tract--application of direct immunofluorescence in the diagnostics of Chlamydia trachomatis in the East Bohemian Region of Czech Republic during 1997-2003]M Förstl, V Stepánová, V Buchta, et al.Bioorganic & Medicinal Chemistry|February 27, 2007
Hybrid molecules of estrone: new compounds with potential antibacterial, antifungal, and antiproliferative activitiesJ Adamec, R Beckert, D Weiss, et al.Folia Microbiologica|December 31, 2002
In vitro antifungal activity of 3-phenyl-2H-benzoxazine-2,4(3H)-dionesK Waisser, L Kubicová, V Buchta, et al.Journal of Medicinal Chemistry|August 10, 2001
3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones: synthesis and biological activity of a novel group of potential antifungal drugsM Pour, M Spulák, V Buchta, et al.Ceska Gynekologie|July 24, 2008
[Recurrent vulvovaginal candidiasis--possibility of its treatment]J Spacek, V Buchta, P Jílek, et al.Pageof 5